polatuzumab vedotin
roche
['pola', 'dlbcl', 'lymsm']
#17icml| georg lenz, presents retrospective data on pola-r-chp vs r-choep in young pts with previously untreated high-risk dlbcl. both regimens had similar efficacy. pola-r-chp had a more favorable safety profile, thus is the preferred treatment in these pts
#lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm